Roxadustat for CKD Anemia - Starting the Jigsaw Puzzle, What Will the Finished Picture Show?

Affiliations

Editorial

Wolfgang C Winkelmayer et al. Kidney Int Rep. 2021.

. 2021 Feb 4;6(3):559-561.

doi: 10.1016/j.ekir.2021.01.035. eCollection 2021 Mar.

¹ Department of Medicine, Section of Nephrology, Baylor College of Medicine, Houston, Texas, USA.

Retraction in

Retraction notice to "Roxadustat for CKD Anemia - Starting the Jigsaw Puzzle, What Will the Finished Picture Show?" Kidney Int Rep. 2021;6:559-561.
Winkelmayer WC, Walther CP. Winkelmayer WC, et al. Kidney Int Rep. 2022 Feb 5;7(3):665. doi: 10.1016/j.ekir.2022.01.1070. eCollection 2022 Mar. Kidney Int Rep. 2022. PMID: 35257088 Free PMC article.

No abstract available

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.
Provenzano R, Fishbane S, Szczech L, Leong R, Saikali KG, Zhong M, Lee TT, Houser MT, Frison L, Houghton J, Little DJ, Peony Yu KH, Neff TB. Provenzano R, et al. Kidney Int Rep. 2020 Dec 24;6(3):613-623. doi: 10.1016/j.ekir.2020.12.018. eCollection 2021 Mar. Kidney Int Rep. 2020. Retraction in: Kidney Int Rep. 2022 Feb 05;7(3):665. doi: 10.1016/j.ekir.2022.01.1069. PMID: 33732976 Free PMC article. Retracted.
Roxadustat for CKD-related Anemia in Non-dialysis Patients.
Coyne DW, Roger SD, Shin SK, Kim SG, Cadena AA, Moustafa MA, Chan TM, Besarab A, Chou W, Bradley C, Eyassu M, Leong R, Lee TT, Saikali KG, Szczech L, Yu KP. Coyne DW, et al. Kidney Int Rep. 2020 Dec 5;6(3):624-635. doi: 10.1016/j.ekir.2020.11.034. eCollection 2021 Mar. Kidney Int Rep. 2020. PMID: 33732977 Free PMC article.

1. U.S. Congress, Office for Technology Assessment, Recombinant Erythropoetin: Payment Options for Medicare, OTA-H-451 (Washington, D.C., U.S. Government Printing Office, May 1990)
1. U.S. Food and Drug Administration Procrit(R) Epoetin Alfa — Label 4/1/1993. https://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/103234s1015_L... Available at:
1. Besarab A., Bolton W.K., Browne J.K. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339(9):584–590. - PubMed
1. Singh A.K., Szczech L., Tang K.L. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355(20):2085–2098. - PubMed
1. Pfeffer M.A., Burdmann E.A., Chen C.Y. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361(21):2019–2032. - PubMed